A clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases.


Updates from The Motley Fool

Latest updates on Arena Pharmaceuticals from Fool.com.  The Fool has written over 400 articles on Arena Pharmaceuticals.
One Biotech Turnaround to Watch

Arena Pharmaceuticals has turned its bad luck around, and could be on the path to something huge.



Stock Performance

View Interactive ARNA Charts
Sponsored by

Key Data Points

Primary metrics and data points about Arena Pharmaceuticals.
Current Price: $43.88
Prev Close: $44.57
Open: $44.66
Bid: $40.02
Ask: $43.80
Day's Range: $43.05 - $44.82
52wk Range: $20.02 - $50.05
Volume: 389,921
Avg Vol 569,378
Market Cap: $2B
P/E (ttm): -16.21
EPS (ttm): ($2.75)
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Arena Pharmaceuticals.
CAPS Rating 2 out of 5
 
763 Outperform
75 Underperform
CAPS All Stars
 
117 Outperform
17 Underperform

How do you think Arena Pharmaceuticals will perform against the market?



You pick for Arena Pharmaceuticals is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Amit Munshi, CEO

90% Approve

Based on 7 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Arena Pharmaceuticals.

A clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers